Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
173M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
32.8M
-
Shares change
-
+15M
-
Total reported value, excl. options
-
$1.64B
-
Value change
-
+$750M
-
Number of buys
-
70
-
Number of sells
-
-12
-
Price
-
$50.42
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q3 2023
89 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q3 2023.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.8M shares
of 173M outstanding shares and own 18.96% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (2.51M shares), Driehaus Capital Management LLC (2.39M shares), JANUS HENDERSON GROUP PLC (2.09M shares), Deep Track Capital, LP (1.92M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.8M shares), BVF INC/IL (1.75M shares), FMR LLC (1.59M shares), T. Rowe Price Investment Management, Inc. (1.57M shares), TCG Crossover Management, LLC (1.5M shares), and Casdin Capital, LLC (1.26M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.